Organoselenium and organotellurium compounds: toxicology and pharmacology.

  title={Organoselenium and organotellurium compounds: toxicology and pharmacology.},
  author={Cristina Wayne Nogueira and Gilson Rog{\'e}rio Zeni and Jo{\~a}o Batista T Rocha},
  journal={Chemical reviews},
  volume={104 12},
The organoselenium and organotellurium compounds have been described as promising pharmacological agents in view of their unique biological properties. Glutathione peroxidase mimic, antioxidant activity and thioredoxin reductase inhibition are some of the properties reviewed here. On the other hand, little is known about the molecular toxicological effects of organoselenium and organotellurium compounds. Most of our knowledge arose from research on inorganic selenium and tellurium. However, the… Expand
Pharmacology of Organotellurium Compounds
This chapter discusses the pharmacology of organotellurium compounds. Glutathione plays a central role in endogenous antioxidant defence as a reducing agent and nucleophile, as well as a substrateExpand
Organoselenium and organotellurium compounds: Toxicology and pharmacology
In the last three decades, the interest in the field of synthesis and reactivity of organoselenium and organotellurium compounds has increased; particularly, in view of the observations that they canExpand
Toxicology and pharmacology of synthetic organoselenium compounds: an update
The outcomes of the clinical trials of ebselen as a mimetic of lithium or as an inhibitor of SARS-CoV-2 proteases will be important to the field of organoselenium synthesis. Expand
The Thiol-Modifier Effects of Organoselenium Compounds and Their Cytoprotective Actions in Neuronal Cells
The results suggest that the biological effects elicited by these compounds are not directly related to their GPx-mimetic and thiol oxidase activities, but might be linked to the up-regulation of endogenous antioxidant defences trough their thiol-modifier effects. Expand
Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds
The potential therapeutic use of simple organoselenium compounds has not yet been sufficiently explored and this class of compounds cannot discard as promising pharmaceutical agents, in effect, the future of the organochalcogens as pharmacological agents will depend on more detailed toxicological studies in the oncoming years. Expand
Organochalcogen peroxidase mimetics as potential drugs: a long story of a promise still unfulfilled.
The various chemical aspects of the reaction mechanism of peroxidase mimetics are surveyed here, focusing on experimental evidence and quantum mechanics calculations of organochalcogen representatives of the various classes. Expand
Diethyl 2-phenyl-2 tellurophenyl vinylphosphonate: an organotellurium compound with low toxicity.
The results suggest that this novel organotellurium compound interacts with the sulfhydryl groups, however only at higher doses when compared with diphenyl ditelluride. Expand
Organoselenium compounds as mimics of selenoproteins and thiol modifier agents.
The exploitation of the thiol modifier properties of organoselenium compounds can be harnessed more rationally than the use of low mass molecular structures to mimic the activity of high mass macromolecules that have been shaped by millions to billions of years of evolution. Expand
Diphenyl Ditelluride: Redox-Modulating and Antiproliferative Properties
Recent advances in the understanding of the biological effects, therapeutic potential, and safety of DPDT treatment are presented and emerging approaches for possible future applications are inferred. Expand
Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in Caenorhabditis elegans by preventing oxidative stress.
It is established that the organochalcogens DPTVP and ebselen act as antiaging agents in a model of Mn-induced toxicity and aging by regulating DAF-16/FOXO signaling and attenuating oxidative stress. Expand